Company Overview and News

 
Trump Tariffs Are a Boon for This French Steelmaker - Bloomberg

2018-03-02 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Vallourec's (VLOUF) CEO Philippe Crouzet on Q4 2017 Results - Earnings Call Transcript

2018-02-22 seekingalpha
Thank you. Good evening, everyone. I am very pleased to be with you tonight to comment on the great achievements we made this year and starting with a breakevening on EBITDA, and of course, the debt level as well.
Upvote Downvote

 
Vallourec SA 2017 Q4 - Results - Earnings Call Slides

2018-02-21 seekingalpha
The following slide deck was published by Vallourec SA in conjunction with their 2017 Q4 earnings call.
Upvote Downvote

 
Even Your Mom Can't Protect You in an Insider-Trading Case - Bloomberg

2017-12-20 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Vallourec SA's (VLOUF) CEO Philippe Crouzet on Q3 2017 Results - Earnings Call Transcript

2017-11-10 seekingalpha
Good day and welcome to the Vallourec Q3 and First Nine Months Results 2017 Conference Call. Today's conference is being recorded.
Upvote Downvote

1
Vallourec SA 2017 Q3 - Results - Earnings Call Slides

2017-11-10 seekingalpha
The following slide deck was published by Vallourec SA in conjunction with their 2017 Q3 earnings call.
Upvote Downvote

2
Seamless Pipes - Global Market Outlook (2017-2023)

2017-10-03 prnewswire
LONDON, Oct. 3, 2017 /PRNewswire/ -- According to Stratistics MRC, the Global Seamless Pipes Market is accounted for $176.95 billion in 2016 and is expected to reach $270.65 billion by 2023 growing at a CAGR of 6.2% during the forecast period. Download the full report: https://www.reportbuyer.com/product/5126521 Growing demand for seamless pipes from the oil & gas industry and flexible pipes are some of the key factors favouring the market growth.
Upvote Downvote

 
Seamless Pipes Market by Type, Production Process, Cross-roll Piercing & Pilger Rolling, Material, End-use Industry, and Region - Global Forecast to 2022

2017-07-13 prnewswire
LONDON, July 13, 2017 /PRNewswire/ -- "The seamless pipes market is projected to grow at a CAGR of 5.2% from 2017 to 2022, in terms of value" The seamless pipes market is estimated to be USD 183.79 billion in 2017 and is projected to reach USD 237.11 billion by 2022, at a CAGR of 5.2% during the forecast period. The demand for seamless pipes is majorly driven by the increasing demand for seamless pipes from the oil & gas sector.
Upvote Downvote

 
$103.8 Billion Growth Opportunities in Global Small Diameter Pipe Market, 2021 - Research and Markets

2017-05-24 prnewswire
Research and Markets has announced the addition of the "Growth Opportunities in Global Small Diameter Pipe Market" report to their offering.
Upvote Downvote

 
Vallourec SA's (VLOUF) CEO Philippe Crouzet on Q1 2017 Results - Earnings Call Transcript

2017-04-27 seekingalpha
Good day ladies and gentlemen and welcome to the Vallourec first quarter 2017 results conference call. Today’s conference is being recorded. At this time I would like to turn the conference over to Mr. Etienne Bertrand, Head of Investor Relations, please go ahead sir.
Upvote Downvote

 
Growth Opportunities in Global Small Diameter Pipe Market

2017-03-30 prnewswire
NEW YORK, March 30, 2017 /PRNewswire/ -- Trends, opportunities and forecast in this market to 2022 by material (metal pipe, plastic pipe, concrete pipe, FRP pipe and others), application (potable water pipe, wastewater pipe, oil and gas pipe, industrial application pipe, and others), diameter (0 to 5 inches, 6 to 10 inches, and 11 to 15 inches), and region (North America, Europe, and Asia Pacific (APAC) and the Rest of the World (ROW) The future of global small diameter pipe market looks good with opportunities in potable water and wastewater pipe, oil and gas, and industrial pipe segments.
Upvote Downvote

 
A Billionaire in La La Land - Bloomberg Gadfly

2017-02-24 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Vallourec SA's (VLOUF) CEO Philippe Crouzet on Q4 2016 Results - Earnings Call Transcript

2017-02-23 seekingalpha
Good evening. You know me, Etienne Bertrand. I’m the Head of IR at Vallourec. Tonight, we will present you the full-year 2016 results. With me, Philippe Crouzet, CEO; Olivier Mallet, CFO; Jean-Pierre Michel, COO; Didier Hornet, Senior Vice President Eastern Hemisphere; and on the phone from the U.S., Nicolas de Coignac, Senior Vice President North America.
Upvote Downvote

 
Vallourec SA 2016 Q4 - Results - Earnings Call Slides

2017-02-23 seekingalpha
The following slide deck was published by Vallourec SA in conjunction with their 2016 Q4 earnings call.
Upvote Downvote

 
Family Comes First for Billionaire Raider - Bloomberg Gadfly

2017-01-09 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...